In the area of prognostic markers in AML, what do community providers need to know to be up-to-date?

Dr. Brian Druker explains what community providers need to know in order to best treat AML utilizing prognostic features in their patients.

Published on May 31, 2017 in Treatment

What are the latest updates on the Beat AML Master Trial?

Join Dr. Druker as he discusses the Beat AML Master Trial and how it aims to advance treatment for patients by better understanding genomics and driving mutations in these patients.

Published on May 31, 2017 in Treatment

Immunotherapy in AML: Monoclonal Antibodies

In this interview, Dr. Naval Daver provides insight into clinical trials using monoclonal antibodies to achieve complete remission in patients with AML.

Published on May 26, 2017 in Treatment